Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Issued (2016 - 2025)

Historic Shares Issued for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to -$8000.0.

  • Lifecore Biomedical, Inc. \De\'s Shares Issued changed N/A to -$8000.0 in Q2 2025 from the same period last year, while for May 2025 it was $23.8 million, marking a year-over-year increase of 319419.89%. This contributed to the annual value of $23.8 million for FY2025, which is 319419.89% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Shares Issued of -$8000.0 as of Q2 2025.
  • Lifecore Biomedical, Inc. \De\'s Shares Issued's 5-year high stood at $23.8 million during Q4 2024, with a 5-year trough of -$178000.0 in Q1 2023.
  • Its 4-year average for Shares Issued is $4.2 million, with a median of $17000.0 in 2025.
  • Data for Lifecore Biomedical, Inc. \De\'s Shares Issued shows a peak YoY increase of 9986.19% (in 2024) and a maximum YoY decrease of 9986.19% (in 2024) over the last 5 years.
  • Lifecore Biomedical, Inc. \De\'s Shares Issued (Quarter) stood at $5.0 million in 2022, then tumbled by 85.52% to $724000.0 in 2023, then soared by 3192.82% to $23.8 million in 2024, then tumbled by 100.03% to -$8000.0 in 2025.
  • Its Shares Issued stands at -$8000.0 for Q2 2025, versus $17000.0 for Q1 2025 and $23.8 million for Q4 2024.